Document:

aray-ex104_118.htm

 

Exhibit 10.4

 

 

		
	

	

 

August 14, 2018

 

Shig Hamamatsu

 

via email

 

Offer Letter

 

Dear Shig,

 

Accuray Incorporated (the “Company”) is pleased to extend this Offer Letter for you to assume the role of the Company’s Interim Chief Financial Officer in addition to your role as VP, Finance and Chief Accounting Officer.  The effective date of this interim role will be October 1, 2018 and during such time you will be reporting directly to the Company’s Chief Executive Officer.

 

The terms of this Offer Letter are as follows:

 

	
1.
	
Compensation: Solely during the period that you are the Company’s Interim Chief Financial Officer, you will receive additional annual base salary of $50,000, which shall be in addition to your current annual base salary of $325,000, paid in accordance with the Company’s regular payroll practices and subject to applicable withholdings.  Employee salaries are currently paid on a bi-weekly payroll schedule, every other Friday.  The Company reserves the right to change your compensation, hours, duties and benefits as it deems necessary.

 

	
2.
	
Corporate Bonus: Solely during the period that you are the Company’s Interim Chief Financial Officer, your target bonus percentage will be increased to a total of fifty percent (50%).  For the avoidance of doubt, in the event that you are only the Company’s Interim Chief Financial Officer for a portion of a particular fiscal year, then your target bonus percentage for such fiscal year will be prorated based on the number of days that you were in the Interim Chief Financial Officer role during such fiscal year relative to the number of days that you were not in such role, taking into account the target bonus percentages applicable to each role that you held.  By way of example only, if you assumed the role of Interim Chief Financial Officer for 182 days in a fiscal year with a target bonus percentage of fifty percent (50%) and for the other 183 days in such fiscal year you were not the Interim Chief Financial Officer and had a target bonus percentage of thirty-five (35%), then your prorated target bonus percentage would be approximately forty-two and one half percent (42.5%).

 

 

		
	
Shig Hamamatsu

August 14, 2018
	
Page 2 of 4

 

	
3.
	
Restricted Stock Units:  If you accept this offer, we will recommend to the Board of Directors of the Company or its delegated committee that you be granted twenty-five thousand (25,000) restricted stock units (“RSUs”) under the Accuray Incorporated 2016 Equity Incentive Plan. The grant of the RSUs is subject to and conditioned on approval of the grant and its terms by the Board of Directors of the Company or its delegated committee.  One hundred percent (100%) of the RSUs shall vest on December 31, 2019, subject to your continuous status as a service provider through such date.  The RSUs will be subject to all of the terms and conditions of the 2016 Equity Incentive Plan and the form of restricted stock unit award agreement adopted thereunder.

 

	
4.
	
Termination of Employment:  Solely during the period that you are the Company’s Interim Chief Financial Officer and for twelve (12) months thereafter, in the event that the Company terminates your employment without Cause (as defined below) or you resign from such employment for Good Reason (as defined below), then, if you execute a separation agreement and general release in form and substance acceptable to the Company (the “Release”) and the same becomes irrevocable pursuant to its terms within the 60-day period following your termination of employment, you will also be eligible to receive:

 

	
 
	
a.
	
payment of the equivalent of your base salary without regard to any reduction that would otherwise constitute Good Reason you would have earned over the next six (6) months following the termination date (less necessary withholdings and authorized deductions) at your then current base salary rate, payable in a lump sum on the first regularly scheduled payroll date following the date the Release becomes effective and irrevocable (the “Release Effective Date”), but in any event within ten (10) business days of the Release Effective Date; 

 

	
 
	
b.
	
payment of a prorated portion of the actual bonus you would have otherwise received for the fiscal year during which the termination occurs, as if you had remained employed by the Company through the date that would have otherwise been required to earn the bonus, but without the Board or any committee of the Board exercising any negative discretion to reduce the amount of the award, calculated by dividing the number of days from the start of the fiscal year through the termination date by 365 and multiplying the amount of such actual bonus you would have otherwise received by this percentage (but not by more than 100%), and paid at the same time as bonuses are paid to other Company executives that are similarly situated to you; provided, however, that if the termination date is after the seventh month of the fiscal year, the actual bonus will not be prorated and you will receive 100% of such actual bonus you would have otherwise received for that fiscal year at the same time as bonuses are paid to other Company executives that are similarly situated to you; 

 

	
 
	
c.
	
to the extent permissible under applicable law, reimbursement of insurance premiums payable to retain group health coverage as of the termination date for you and your eligible dependents pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986 (“COBRA”) for six (6) months or the maximum period of COBRA coverage, whichever is less; provided that you must submit a reimbursement request in accordance with Company policy within thirty (30) days of paying such insurance premiums.  The Company will reimburse you within thirty (30) days of receiving a properly submitted request. In addition, if you accept other employment within such six (6) months, the Company’s obligation under this subsection (c) will be extinguished as of the date you become covered under the group health plan of your new employer; and

 

 

		
	
Shig Hamamatsu

August 14, 2018
	
Page 3 of 4

 

 

	
 
	
d.
	
payment for executive outplacement assistance services with the Company’s then current outplacement services vendor and in accordance with the Company’s then current policies and practices with respect to outplacement assistance for other executives of the Company for up to twelve (12) months after the termination date.

 

For the sake of clarity, if any payments or benefits are payable under the Change in Control Agreement between you and the Company, effective as of September 21, 2017 (the “Change in Control Agreement”), then such payments and benefits thereunder will be reduced by any payments and benefits paid or provided to you under this Section 4.

 

As used in this Section 4, “Cause” shall mean any of the following conduct by you:  (i) material breach of this Offer Letter, the Offer of Employment between you and the Company, dated as of July 24, 2017 (the “Offer of Employment”), any confidentiality or invention assignment between you and the Company, or of a Company policy or of a law, rule or regulation applicable to the Company or its operations; (ii) demonstrated and material neglect of duties, or failure or refusal to perform the material duties of your position, or the failure to follow the reasonable and lawful instructions of the Company; (iii) gross misconduct or dishonesty, self-dealing, fraud or similar conduct that the Company reasonably determines has caused, is causing or reasonably is likely to cause harm to the Company; or (iv) conviction of or plea of guilty or nolo contendere to any crime other than a traffic offense not punishable by a sentence of incarceration.  Termination pursuant to clause (ii) of this definition shall be effective only if such failure continues after you have been given written notice thereof and fifteen (15) business days thereafter in which to present your position to the Company or to cure the same, unless the Company reasonably determines that the reason(s) for termination are not capable of being cured.

 

As used in this Offer Letter, “Good Reason” shall mean the occurrence of any one of the following without your written consent:  (i) a material reduction in your base compensation (which includes base salary, target bonus and any other base compensation) other than as a result of your relinquishment of the Interim Chief Financial Officer role so long as you receive your base salary that was in effect immediately prior to your assumption of such role, (ii) any action or inaction that constitutes a material breach by the Company of this Offer Letter or the Offer of Employment; (iii) a material diminution in your authority, duties or responsibilities such that they are materially inconsistent with your position as Vice President, Finance and Chief Accounting Officer of the Company (it being understood that relinquishment of the Interim Chief Financial Officer role shall not constitute a material diminution under this clause (iii)); and (iv) relocation of the Company’s headquarters to a location that materially increases your commute, provided that no termination for Good Reason shall be effective until you have given the Company written notice within sixty (60) days after you become aware of the initial occurrence of any of the foregoing specifying the event or condition constituting the Good Reason and the specific reasonable cure requested by you, and the Company has failed to cure the occurrence within thirty (30) days of receiving written notice from you, and you resign within six (6) months after you become aware of the initial occurrence.

 

 

 

		
	
Shig Hamamatsu

August 14, 2018
	
Page 4 of 4

 

	
5.
	
At-Will Employment:  Notwithstanding the foregoing, you should be aware that your employment with the Company continues to be for no specified period and constitutes "at-will" employment.  As a result, you are free to terminate your employment at any time, for any reason or for no reason.  Similarly, the Company is free to terminate your employment at any time, for any reason or for no reason.  In the event of termination of your employment, you will not be entitled to any payments, benefits, damages, awards, or compensation other than (a) as may otherwise be available in accordance with the Company's established employee plans and policies at the time of termination, (b) as set forth in Section 4 above, or (c) as set forth in your Change in Control Agreement.

 

To indicate your acceptance of this offer of the interim role, please sign, and date below and return to us no later than August 15, 2018.  This Offer Letter, the Offer of Employment, the Change in Control Agreement, the employee Confidentiality and Inventions Agreement between you and the Company, and the agreements memorializing your currently outstanding Company equity awards, constitute the entire agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all prior negotiations, representations or agreements between you and the Company. 

 

We look forward to your continued success in your interim role.

 

Sincerely,

 

/s/ Joshua H. Levine

 

Joshua H. Levine

President and Chief Executive Officer

 

 

I have read and understand this offer letter and hereby acknowledge, accept and agree to the terms as set forth above. I further acknowledge that no other commitments were made to me as part of my acceptance of the Interim Chief Financial Officer role except as specifically set forth herein. 

 

 

/s/ Shig Hamamatsu

Signature

 

8/15/18

Datearay-ex105_119.htm

Exhibit 10.5

Page 1 of 8

CONSULTING AGREEMENT

This Consulting Agreement (this “Agreement”) is made and entered into by and between Kevin Waters (“CONSULTANT”) and Accuray Incorporated (“ACCURAY”), effective as of October 2, 2018 (“Effective Date”).  

W I T N E S S E T H

WHEREAS, CONSULTANT voluntarily resigned from CONSULTANT’s employment with ACCURAY effective as of October 1, 2018;

WHEREAS, CONSULTANT has training, expertise and prior experience in the executive management of ACCURAY and its Finance department; 

WHEREAS, ACCURAY desires to retain the services of CONSULTANT to provide the consulting services specified in this Agreement; and

WHEREAS, CONSULTANT desires to provide consulting services for the benefit of ACCURAY and its related entities using CONSULTANT’s knowledge, skills, experience and abilities; 

NOW THEREFORE, in consideration of the mutual promises contained herein, and other good and valuable consideration, the parties hereto agree as follows:

ARTICLE I - SERVICES TO BE PROVIDED

A.  Nature of Services.  CONSULTANT shall be available to (1) provide advice and assistance to ACCURAY and its related entities, and specifically to ACCURAY’s (a) Chief Executive Officer, (b) Interim Chief Financial Officer, (c) Senior Vice President, Human Resources, (d) Chief Commercial Officer, (e) Interim General Counsel, and (f) other members of ACCURAY management, with respect to various questions, initiatives and projects related to the management of the Finance function and (2) continue to provide services as requested in connection with ACCURAY’s China joint venture initiative (collectively, “Services”), in each case on an as needed basis as determined by Accuray, up to a maximum of 80 hours of Services each month during the Term of this Agreement.

B.  Right of Control.  CONSULTANT shall have exclusive control over the means, manner, methods and processes by which the Services are performed.

C.  Exclusive Services.  CONSULTANT shall use his best efforts to provide, and to devote CONSULTANT’S undivided attention and effort in providing, the Services as required by ACCURAY.  To facilitate the foregoing and to ensure compliance with the obligations in Article IV of this Agreement, CONSULTANT agrees that CONSULTANT will not accept any employment or engage in any other consulting, business and/or commercial activities with the following entities: Varian Medical Systems, Elekta AB, Siemens AG, Mitsubishi Heavy Industries, Brainlab AG, ViewRay Inc., Best Medical, Rotary Systems, Radiation Stabilization 

1

Page 2 of 8

 

Solutions, Alliance Oncology, MedyTec, Oncology Systems Limited, Rotary Systems Incorporated, Cowealth Medical Holding Co., Ltd. or any of their respective affiliates (the “Prohibited Entities”).  In addition, in the event CONSULTANT intends to provide services related in any way to radiation oncology, including radiosurgery or radiation therapy, during the Term of this Agreement to any entity other than a Prohibited Entity, CONSULTANT shall notify ACCURAY’s Chief Executive Officer to get approval by ACCURAY and such approval shall not be unreasonably withheld.  In the event CONSULTANT desires to provide work to any of the above, then both parties could mutually agree to terminate this agreement in writing, such agreement not to be unreasonably withheld.

ARTICLE II - COMPENSATION FOR SERVICES

A.  Consulting Consideration.  As sole consideration for CONSULTANT’s performance of the Services, ACCURAY shall provide CONSULTANT with:

(1)a monthly payment in the amount of Thirty Thousand Dollars ($30,000), payable within five (5) days of the end of each month during the Term;

(2)continued vesting of CONSULTANT’S outstanding ACCURAY equity awards as detailed in subsection B below; 

(3)continued coverage under ACCURAY’s directors and officers insurance policies for so long as CONSULTANT remains as an officer or director of ACCURAY or any of its affiliate entities; and

(4)the ability to keep CONSULTANT’s ACCURAY-issued laptop provided that such laptop is first provided to the Company to remove any of ACCURAY’s confidential information, proprietary information, and software licensed to ACCURAY.

B.  Equity. No additional equity will be granted under this Agreement, however, any currently outstanding equity awards granted by Accuray to CONSULTANT shall continue to vest in accordance with the terms thereof until the expiration or earlier termination of the Term.

C.  Reimbursement of Authorized Expenses.  ACCURAY agrees to reimburse CONSULTANT for all actual out-of-pocket expenses that are necessary for the performance of CONSULTANT’s Services under this Agreement, provided, however, that any expenses must be approved in advance in writing by ACCURAY’s Chief Executive Officer.

D.  Tax Obligations.  CONSULTANT understands and agrees that all compensation to which CONSULTANT is entitled under the Agreement shall be reported on an IRS Form 1099, and that CONSULTANT is solely responsible for all income and/or other tax obligations, if any, including but not limited to all reporting and payment obligations, if any, which may arise as a consequence of any payment under this Agreement.

2

Page 3 of 8

 

E.  No Benefits.  CONSULTANT understands and agrees that since CONSULTANT is no longer an employee of ACCURAY, CONSULTANT shall not, except as expressly set forth in Section A of Article II above, be entitled to participate in ACCURAY employee benefits plans or receive any benefits provided to employees of ACCURAY, including, but not limited to participation in retirement savings or benefit plans, bonus plans and/or stock option plans beyond CONSULTANT’s participation during CONSULTANT’s employment by ACCURAY; holidays off with pay; vacation time off with pay; paid leaves of absence of any kind; and insurance coverage of any kind, specifically including, but not limited to, medical and dental insurance, workers’ compensation insurance and state disability insurance, but excluding any insurance coverage CONSULTANT may be entitled to that extend, pursuant to its terms, through the last day of the month in which CONSULTANT ceased to be an employee of ACCURAY, which insurance coverage will terminate as of the last day of such month.

ARTICLE III - TERM AND TERMINATION

A.  Term of Agreement.  This Agreement shall continue in full force and effect from the Effective Date through December 31, 2018, unless extended at ACCURAY’s request (the “Term”) or earlier terminated pursuant to subsection B below.

B.  Termination Prior to Expiration of Term.  ACCURAY may terminate this Agreement for Cause (as defined in the Employment Agreement between the ACCURAY and CONSULTANT dated January 1, 2018 (the “Executive Employment Agreement”)) before the expiration of the Term hereof without any prior notice.

ARTICLE IV -- PROPRIETARY RIGHTS AND NON-SOLICITATION

A.  No Impediments to Providing Consulting Services.  CONSULTANT represents that CONSULTANT is not party to any agreement with any individual or business entity, including any relating to protection of alleged trade secrets or confidential business information that would prevent CONSULTANT from providing the Services or that would be violated by the providing of the Services.

B.  Confidential and Proprietary Information.  CONSULTANT acknowledges that the post-employment terms of the ACCURAY Employee Invention Assignment and Confidentiality Agreement, the Employment Agreement that existed before this Agreement and any release agreement that may be entered into between ACCURAY and CONSULTANT, remain in full force and effect, specifically including the prohibitions against using or disclosing any of ACCURAY’s trade secrets or proprietary and/or confidential information learned while employed by ACCURAY during any subsequent employment.  CONSULTANT also acknowledges that during the Term, CONSULTANT will have access to and learn additional confidential information and/or trade secrets regarding the business of ACCURAY and its related entities, including, but not limited to, radio surgery and radiation therapy devices, and various other business, financial, technical and employee information (collectively, “Confidential and Proprietary Information”).  

3

Page 4 of 8

 

C.  Restrictions on Use and Disclosure of Confidential and Proprietary Information.  In addition to the confidential information obligations that continue from the period of CONSULTANT’s employment with ACCURAY, CONSULTANT agrees to hold all Confidential and Proprietary Information in trust and in the strictest of confidence, and to protect the Confidential and Proprietary Information from disclosure, and to only use such Confidential and Proprietary Information as required to perform the Services hereunder.  CONSULTANT further agrees that CONSULTANT will not, directly or indirectly, use, publish, disseminate or otherwise disclose any Confidential and Proprietary Information to any third party without the prior written consent of ACCURAY, which may be withheld in its absolute discretion.  

D.  Return of Property.  CONSULTANT agrees not to remove any property of ACCURAY or its related entities from their premises without express permission, and to return all such property, including computer data, written materials provided to or obtained during the term of this Agreement, customer and supplier address lists, and any other items of value at the time this Agreement is terminated.

E.  Violations.  CONSULTANT agrees that ACCURAY and its related entities would be irreparably harmed by any actual or threatened violation of the promises in this Article IV, and therefore, that, in addition to other remedies, ACCURAY and its related entities will be entitled to an injunction prohibiting CONSULTANT from committing any such violations.

F.  Non-Solicitation of Employees.  CONSULTANT recognizes the substantial expenditure of time and effort which ACCURAY devotes to the recruitment, hiring, orientation, training and retention of its employees.  Accordingly, CONSULTANT agrees that, for a period beginning on the Effective Date and ending June 30, 2020, CONSULTANT shall not, directly or indirectly, for himself or on behalf of any other person or entity, solicit, offer employment to, hire or otherwise retain the services of any employee of ACCURAY that has a title of vice president or above.  For purposes of the foregoing, “employee of ACCURAY” shall include any person who was an employee of ACCURAY at any time within six (6) months prior to the prohibited conduct.  This provision shall survive any termination of this Agreement and shall be in addition to any non-solicitation obligations that CONSULTANT may have that survived the termination of CONSULTANT’s employment relationship with ACCURAY.

ARTICLE V -- MISCELLANEOUS PROVISIONS

A.  Independent Contractor Status.  CONSULTANT understands and agrees that CONSULTANT is an independent contractor and not an employee of ACCURAY and that CONSULTANT shall not become an employee of ACCURAY by virtue of the performance of the services called for under this Agreement.

B.  No Office Space.  CONSULTANT understands and agrees that CONSULTANT will not be provided with a regular office or access to telephone, clerical support, facsimile or internet services at ACCURAY.  CONSULTANT shall at CONSULTANT’s own expense acquire, operate, maintain and repair or replace any office and equipment and supplies as maybe required for CONSULTANT’s performance of consulting services under this Agreement.  

4

Page 5 of 8

 

C.  Subconsultants and Other Contractors.  CONSULTANT is not authorized to engage the services of subconsultants, vendors or other contractors on behalf of ACCURAY or its related entities, unless CONSULTANT has obtained written authorization from ACCURAY to do so in advance.  To the extent such advance authorization has been obtained, ACCURAY will pay for the services provided by such subconsultants, vendors and/or other contractors. 

D.  Consultant’s Employees.  To the extent CONSULTANT has any employees as of the date CONSULTANT signs this Agreement or hires any employees during the Term of this Agreement, CONSULTANT understands and agrees that all such employees shall be CONSULTANT’s employees only, and that ACCURAY shall not be an employer of the employees.  ACCURAY shall have no responsibility for providing and shall not provide directions, instructions or supervision to any of CONSULTANT’s employees.  Only CONSULTANT shall provide such directions, instructions and supervision.  In addition, all decisions with respect to the employment of CONSULTANT’s employees, if any, shall be made solely and exclusively by CONSULTANT.  ACCURAY shall have no responsibility for or input into such decisions.  CONSULTANT hereby agrees to indemnify, defend and hold ACCURAY harmless from and against any costs, losses, damages, obligations, liabilities and expenses, including attorneys’ fees, arising from or in connection with any claim asserted by any of CONSULTANT’s employees against ACCURAY based on the employees’ employment with CONSULTANT, such as claims for discrimination in employment, harassment, retaliation, violation of statutory law, and wrongful termination.

E.  No Purchases.  CONSULTANT shall not purchase materials or supplies for the accounts of ACCURAY or its related entities, or otherwise hold CONSULTANT out as being authorized to make purchases for which ACCURAY or its related entities would be billed directly by the seller of the materials or supplies, unless such purchase is authorized in writing by ACCURAY in advance.  

F.  Compliance with Governmental Requirements.  CONSULTANT will maintain in force and/or secure all required licenses, permits, certificates and exemptions necessary for the performance of CONSULTANT’s services under this Agreement, and at all times shall comply with all applicable federal, state and local laws, regulations and orders.

G.  Indemnification.  CONSULTANT shall indemnify and hold ACCURAY and its related entities, and the directors, officers, agents, representatives and employees of all such entities, harmless from and against any and all liabilities, losses, damages, costs, expenses, causes of action, claims, suits, legal proceedings and similar matters, including without limitation reasonable attorneys’ fees, resulting from or arising out of the failure of CONSULTANT or any of CONSULTANT’s employees to comply with and perform fully the obligations hereunder, or resulting from any act or omission on the part of CONSULTANT, provided however that the indemnification shall not apply to any good faith action on the part of the CONSULTANT that is within the scope of this Agreement.  If any cause of action, claim, suit or other legal proceeding is brought against CONSULTANT in connection with any services rendered under this Agreement, CONSULTANT shall promptly notify ACCURAY upon learning of any such proceeding.

5

Page 6 of 8

 

ACCURAY shall indemnify and hold CONSULTANT and CONSULTANT’s agents, employees, representatives and heirs, harmless from and against any and all liabilities, losses, damages, costs, expenses, causes of action, claims, suits, legal proceedings and similar matters, including without limitation reasonable attorneys’ fees, resulting from or arising out of the performance of any act specifically requested or authorized by ACCURAY in connection with this Agreement.  This promise does not apply to any actions arising out of or in connection with CONSULTANT’s operation of any motor vehicle.  If any cause of action, claim, suit or other legal proceeding is brought against ACCURAY in connection with any services provided by CONSULTANT under this Agreement, ACCURAY shall promptly notify CONSULTANT upon learning of any such proceeding.

H.  Notices.  Any and all notices and other communications hereunder shall have been deemed to have been duly given when delivered personally or by e-mail during normal business hours, or 24 hours after being emailed outside of normal business hours or mailed, certified or registered mail, return receipt requested, postage prepaid, in the English language, to the addresses set forth below the signatures of the parties hereto or to such other address as either of the parties hereto may from time-to-time designate to the other party in writing.

I.  Waiver.  No purported waiver by either party hereto of any provision of this Agreement or of any breach thereof shall be deemed a waiver of such provision or breach unless such waiver is in writing signed by the party making such waiver.  No such waiver shall be deemed to be a subsequent waiver of such provision or waiver of any subsequent breach of the same or any other provision hereof.

J.  Severability.  The provisions of this Agreement are severable, and if any part of it is found to be unenforceable, the other paragraphs shall remain fully valid and enforceable.

K.  Arbitration.  This Agreement shall in all respects be interpreted and governed by and under the laws of the State of California.  Any dispute between the parties hereto, including any dispute regarding any aspect of this Agreement or any act which allegedly has or would violate any provision of this Agreement or any law (hereinafter “Arbitrable Dispute”), will be submitted to arbitration through Judicial Arbitration and Mediation Services, Inc. (“JAMS”) in San Jose, California, unless the parties agree to another location, using the JAMS Commercial Arbitration Rules (“JAMS Rules”). The arbitrator shall be an experienced arbitrator licensed to practice law in California and selected in accordance with the JAMS Rules, unless the parties agree to another arbitrator.  Arbitration shall be the exclusive remedy for any such Arbitrable Dispute.  The decision of the arbitrator shall be final, conclusive and binding upon the parties.  Should any party to this Agreement pursue any Arbitrable Dispute by any method other than said arbitration, the responding party shall be entitled to recover from the initiating party all damages, costs, expenses and attorneys’ fees incurred as a result of such action.  This section shall not restrict the right of ACCURAY to go to court seeking injunctive relief for a violation of Article IV of this Agreement, pending the outcome of an arbitration proceeding.  

6

Page 7 of 8

 

L.  Sole and Entire Agreement.  This Agreement sets forth the entire agreement between the parties hereto pertaining to the subject matter hereof, and fully supersedes any and all prior agreements or understandings between the parties hereto, whether written or oral, pertaining to the subject matter hereof.  No change in, modification of, or addition, amendment or supplement to this Agreement shall be valid unless set forth in writing and signed and dated by each of the parties hereto subsequent to the execution of this Agreement.

[REMAINDER OF PAGE INTENIONALLY LEFT BLANK]

7

Page 8 of 8

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the Effective Date set forth above.

 

							
	
/s/ Kevin Waters
	
 
	
ACCURAY INCORPORATED

	
Kevin Waters
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 
	
 
	
 

	
Date:
	
 
	
August 14, 2018
	
 
	
By:
	
 
	
/s/ Joshua H. Levine

	
 
	
 
	
 
	
 
	
Name:
	
 
	
Joshua H. Levine

	
Address:
	
 
	
Title:
	
 
	
President and Chief Executive Officer

	
Most recent on file with the Company
	
 
	
Date:
	
 
	
August 14, 2018

	
 
	
 
	
 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
Address:
	
 
	
1310 Chesapeake Terrace

Sunnyvale, CA 94089

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]